Gold-standard science and common sense: seven takeaways from the 2025 FDA cell and gene therapy roundtable

The US Food and Drug Administration’s (FDA; MD, USA) newly appointed Commissioner of Food and Drugs and newly appointed director of the FDA’s Center for Biologics Evaluation and Research (CBER), joined experts in the cell and gene therapy field to discuss pain points and the role of the FDA in the industry. On June 5, 2025, the FDA hosted a roundtable on cell and gene therapy, livestreamed on YouTube and X, and hosted by CBER. Featuring 23 leading voices in the field from across America, the 3-hour event focused on increasing transparency, innovation and collaboration in an evolving therapeutic landscape....